Sector ratings Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 06:00:00 30/07/26 am AEST			5-day change	1st Jan Change
28.52 ^USD	-1.66%		+0.55%	-7.40%

24/07	Wall Street's Three-Front Squeeze
24/07	One hundred dollars and a market beating

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ARGENX SE	55.01B		A
WUXI APPTEC CO., LTD.	54.24B		AAA
BIONTECH SE	23.38B	-	-	-		-
INSMED INCORPORATED	22.57B	-	A	-		-
WUXI BIOLOGICS (CAYMAN) INC.	20.19B		AAA
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	15.5B	-	AA	-		-
PHARMAESSENTIA CORPORATION	14.2B		AA
EXELIXIS, INC.	14.2B		BB
MADRIGAL PHARMACEUTICALS, INC.	12.42B	-	B	-		-
ARROWHEAD PHARMACEUTICALS, INC.	12.08B	-	BB	-		-
AKESO, INC.	11.28B		B			-
CYTOKINETICS, INCORPORATED	10.79B	-	AA	-		-
SUMMIT THERAPEUTICS INC.	10.01B	-	-	-		-
NUVALENT, INC.	9.83B	-	CCC	-		-
CRINETICS PHARMACEUTICALS, INC.	8.84B	-	BBB	-		-
SPYRE THERAPEUTICS, INC.	8.79B	-	BB	-	-	-
REMEGEN CO., LTD.	8.49B		-
CEREVEL THERAPEUTICS HOLDINGS, INC.	8.19B	-	-	-	-	-	-	-
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	7.74B		BB			-
Average	17.25B		A
Weighted average by Cap.			A